The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents
- PMID: 26455382
- PMCID: PMC4815918
- DOI: 10.1017/ice.2015.254
The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents
Abstract
OBJECTIVE An improved understanding of carbapenem-resistant Klebsiella pneumoniae (CRKP) in long-term acute care hospitals (LTACHs) is needed. The objective of this study was to assess risk factors for colonization or infection with CRKP in LTACH residents. METHODS A case-control study was performed at a university-affiliated LTACH from 2008 to 2013. Cases were defined as all patients with clinical cultures positive for CRKP and controls were those with clinical cultures positive for carbapenem-susceptible K. pneumoniae (CSKP). A multivariate model was developed to identify risk factors for CRKP infection or colonization. RESULTS A total of 222 patients were identified with K. pneumoniae clinical cultures during the study period; 99 (45%) were case patients and 123 (55%) were control patients. Our multivariate analysis identified factors associated with a significant risk for CRKP colonization or infection: solid organ or stem cell transplantation (OR, 5.05; 95% CI, 1.23-20.8; P=.03), mechanical ventilation (OR, 2.56; 95% CI, 1.24-5.28; P=.01), fecal incontinence (OR, 5.78; 95% CI, 1.52-22.0; P=.01), and exposure in the prior 30 days to meropenem (OR, 3.55; 95% CI, 1.04-12.1; P=.04), vancomycin (OR, 2.94; 95% CI, 1.18-7.32; P=.02), and metronidazole (OR, 4.22; 95% CI, 1.28-14.0; P=.02). CONCLUSIONS Rates of colonization and infection with CRKP were high in the LTACH setting, with nearly half of K. pneumoniae cultures demonstrating carbapenem resistance. Further studies are needed on interventions to limit the emergence of CRKP in LTACHs, including targeted surveillance screening of high-risk patients and effective antibiotic stewardship measures. Infect. Control Hosp. Epidemiol. 2015;37(1):55-60.
Similar articles
-
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.Pathog Glob Health. 2015 Mar;109(2):68-74. doi: 10.1179/2047773215Y.0000000004. Epub 2015 Feb 24. Pathog Glob Health. 2015. PMID: 25707874 Free PMC article.
-
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.South Med J. 2011 Feb;104(2):106-10. doi: 10.1097/SMJ.0b013e318206063d. South Med J. 2011. PMID: 21258230
-
Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals.Clin Infect Dis. 2017 Apr 1;64(7):839-844. doi: 10.1093/cid/ciw856. Clin Infect Dis. 2017. PMID: 28013258 Free PMC article.
-
Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in Greece.Future Microbiol. 2016 Jun;11:809-23. doi: 10.2217/fmb-2016-0042. Epub 2016 May 20. Future Microbiol. 2016. PMID: 27206024 Review.
-
Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae.Ann Clin Microbiol Antimicrob. 2017 Mar 29;16(1):18. doi: 10.1186/s12941-017-0191-3. Ann Clin Microbiol Antimicrob. 2017. PMID: 28356109 Free PMC article. Review.
Cited by
-
Carbapenem-Resistant Klebsiella pneumoniae Infection and Its Risk Factors in Older Adult Patients.Clin Interv Aging. 2023 Jul 6;18:1037-1045. doi: 10.2147/CIA.S406214. eCollection 2023. Clin Interv Aging. 2023. PMID: 37435410 Free PMC article.
-
Outbreak of carbapenem-resistant Enterobacterales at a long-term care facility in Seoul, Korea: surveillance and intervention mitigation strategies.Epidemiol Health. 2023;45:e2023057. doi: 10.4178/epih.e2023057. Epub 2023 Jun 9. Epidemiol Health. 2023. PMID: 37321276 Free PMC article.
-
Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study.BMJ Open. 2023 Jun 12;13(6):e065786. doi: 10.1136/bmjopen-2022-065786. BMJ Open. 2023. PMID: 37308270 Free PMC article.
-
Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?Antimicrob Steward Healthc Epidemiol. 2023 Mar 8;3(1):e47. doi: 10.1017/ash.2022.363. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 36970424 Free PMC article.
-
Analysis of risk factors associated with healthcare-associated carbapenem-resistant Klebsiella pneumoniae infection in a large general hospital: a case-case-control study.Eur J Clin Microbiol Infect Dis. 2023 May;42(5):529-541. doi: 10.1007/s10096-023-04578-w. Epub 2023 Mar 1. Eur J Clin Microbiol Infect Dis. 2023. PMID: 36856898 Free PMC article.
References
-
- Bogan C, Kaye KS, Chopra T, et al. Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis. Am J Infect Control. 2014;42:612–620. - PubMed
-
- Borer A, Saidel-Odes L, Riesenberg K, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol. 2009;30:972–976. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
